Whether or not you end up considering VisiFlora specifically, this framework applies to evaluating any eye-health supplement critically.
A "proprietary blend" hides individual ingredient amounts behind one combined total, making it impossible to know if any single ingredient is present at a meaningful dose. Labels that disclose individual amounts — like VisiFlora's — are more transparent by default.
If a label lists lutein, check whether it's close to the 10mg used in AREDS2 — not a token 1–2mg. The same logic applies to zinc, bilberry extract, and other researched ingredients. See our lutein/zeaxanthin guide and bilberry guide for the specific research doses.
These are different claims, and conflating them is one of the most common ways supplement marketing misleads people. An ingredient having published research behind it does not mean the specific multi-ingredient product containing it has been through its own clinical trial — which is why we're upfront that VisiFlora's full formula, like most multi-ingredient supplements, hasn't been through a dedicated trial of its own.
Look for disclosure of where and how a product is made — GMP certification and FDA facility registration are verifiable, meaningful quality signals, unlike vague terms like "premium" or "clinical-grade" that have no regulated definition.
Phrases like "NASA-researched," oddly specific multiplier claims ("6,000x stronger than..."), or appeals to unverifiable authority ("trusted by former pilots") are common in supplement marketing and rarely hold up to scrutiny. Our Research Library explains how we rank evidence and flag this kind of language when we see it.